Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
3.730
+0.130 (3.61%)
At close: Oct 6, 2025, 4:00 PM EDT
3.750
+0.020 (0.54%)
After-hours: Oct 6, 2025, 7:20 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $265.98 million as of October 6, 2025. Its market cap has increased by 58.81% in one year.
Market Cap
265.98M
Enterprise Value
67.32M
1-Year Change
58.81%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $265.98M, a decrease of -66.03%. That is a compound annual growth rate of -23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 265.98M | 71.76% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |